Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Foundation Medicine Company Profile (NYSE:FMI)

Consensus Ratings for Foundation Medicine (NYSE:FMI) (?)
Ratings Breakdown: 5 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.29)
Consensus Price Target: $38.80 (43.54% upside)

Analysts' Ratings History for Foundation Medicine (NYSE:FMI)
Show:
DateFirmActionRatingPrice TargetDetailsShare
6/25/2014Janney Montgomery ScottInitiated CoverageNeutral -> Neutral$28.00ViewTweet This Rating  Share This Rating on StockTwits
5/9/2014Leerink SwannLower Price Target$36.00 -> $33.00ViewTweet This Rating  Share This Rating on StockTwits
4/17/2014William BlairInitiated CoverageMarket PerformViewTweet This Rating  Share This Rating on StockTwits
3/10/2014JMP SecuritiesBoost Price TargetOutperform$33.00 -> $45.00ViewTweet This Rating  Share This Rating on StockTwits
3/4/2014WedbushInitiated CoverageOutperform$50.00ViewTweet This Rating  Share This Rating on StockTwits
2/26/2014Leerink SwannBoost Price Target$35.00 -> $36.00ViewTweet This Rating  Share This Rating on StockTwits
12/18/2013JMP SecuritiesInitiated CoverageOutperform$33.00ViewTweet This Rating  Share This Rating on StockTwits
10/21/2013Sanford C. BernsteinInitiated CoverageMarket PerformViewTweet This Rating  Share This Rating on StockTwits
10/21/2013Goldman SachsInitiated CoverageNeutralViewTweet This Rating  Share This Rating on StockTwits
10/21/2013Leerink SwannInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
10/21/2013JPMorgan Chase & Co.Initiated CoverageNeutral$38.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2012 forward)